FAS and colonic neoplasm: Verticillin A (13) was found to be a new selective HMTase inhibitor that inhibits H3K9me3 to restore Fas expression, indicating that H3K9me3-mediated FAS transcription silencing is a dominant mechanism by which colon cancer cells evade host cancer immune surveillance [83].